Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$30.69
+5.23%
Mkt Cap $3.13B
Next Earnings
In 7 daysTue, May 5, 2026
EPS Estimate
-$1.03
9 analysts
Revenue Estimate
$10.98M
Last quarter: beat by +91.15% on EPS, +877.88% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$3.13B
P/E
—
Fwd P/E
—
P/S
22.37
Rev TTM
—
EPS TTM
-$1.01